About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
Systems modelling of the EGFR-PYK2-c-Met interaction network predicted and prioritized synergistic drug combinations for Triple-negative breast cancer. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "egfrtot_source_parameter",
"label": "EGFRtot source parameter",
"units": "native SBML value",
"default": 398.107,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.egfrtot_source_parameter",
"description": "EGFRtot source parameter. Maps to bundled SBML parameter `EGFRtot`."
},
{
"name": "ca_egf_source_parameter",
"label": "CaEGF source parameter",
"units": "native SBML value",
"default": 0.0891251,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.ca_egf_source_parameter",
"description": "CaEGF source parameter. Maps to bundled SBML parameter `caEGF`."
},
{
"name": "egf_source_parameter",
"label": "EGF source parameter",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.egf_source_parameter",
"description": "EGF source parameter. Maps to bundled SBML parameter `EGF`."
},
{
"name": "initial_pegfr",
"label": "PEGFR",
"units": "native SBML value",
"default": 0.109014,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.initial_pegfr",
"description": "Initial PEGFR. Sets the initial value of bundled SBML symbol `pEGFR`."
},
{
"name": "initial_egfrub",
"label": "EGFRub",
"units": "native SBML value",
"default": 6.93991,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.initial_egfrub",
"description": "Initial EGFRub. Sets the initial value of bundled SBML symbol `EGFRub`."
},
{
"name": "initial_perk",
"label": "PERK",
"units": "native SBML value",
"default": 0.669043,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.initial_perk",
"description": "Initial PERK. Sets the initial value of bundled SBML symbol `pERK`."
}
],
"outputs": [
{
"name": "pegfr",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.pegfr",
"description": "PEGFR observable. Maps to SBML symbol `pEGFR`."
},
{
"name": "egfrub",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.egfrub",
"description": "EGFRub observable. Maps to SBML symbol `EGFRub`."
},
{
"name": "perk",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.perk",
"description": "PERK observable. Maps to SBML symbol `pERK`."
},
{
"name": "pstat3",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.pstat3",
"description": "PSTAT3 observable. Maps to SBML symbol `pSTAT3`."
},
{
"name": "stat3u_stattic",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.stat3u_stattic",
"description": "STAT3uStattic observable. Maps to SBML symbol `STAT3uStattic`."
},
{
"name": "pyk2",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.pyk2",
"description": "PYK2 observable. Maps to SBML symbol `PYK2`."
},
{
"name": "state",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"signal-transduction",
"signaling",
"systemsbiology",
"tumor-growth"
],
"title": "Shin_2018_EGFR-PYK2-c-Met interaction network_model Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model_state"
],
"from": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.state"
},
{
"to": [
"visualisation.oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model_summary"
],
"from": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model_species_labels"
],
"from": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.species_labels"
}
],
"package": "shin-2018-egfr-pyk2-c-met-interaction-network-model",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "Systems modelling of the EGFR-PYK2-c-Met interaction network predicted and prioritized synergistic drug combinations for Triple-negative breast cancer. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageshin-2018-egfr-pyk2-c-met-interaction-network-model
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsignal-transductionsignalingsystemsbiologytumor-growthvisualisationother